HomeAI · summaries
Storia in 2 fonti
At BIO 2026, industry wrestled with Washington politics, and making AI work better
At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
A dispatch on AI from BIOtech’s big summer bash
In this edition of STAT's AI Prognosis: Brittany Trang brings the latest from BIO on how biotech companies are approaching artificial intelligence.
- ·
cryptobriefing.com
Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026
Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life
